UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) – Research analysts at SVB Leerink lifted their FY2025 earnings estimates for shares of UnitedHealth Group in a note issued to investors on Tuesday, May 23rd. SVB Leerink analyst W. Mayo now forecasts that the healthcare conglomerate will post earnings of $32.64 per share for the year, up from their prior estimate of $32.60. The consensus estimate for UnitedHealth Group’s current full-year earnings is $24.98 per share. SVB Leerink also issued estimates for UnitedHealth Group’s FY2026 earnings at $37.36 EPS.
UNH has been the topic of several other research reports. StockNews.com began coverage on UnitedHealth Group in a research note on Thursday, May 18th. They set a “strong-buy” rating on the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $617.00 to $627.00 in a report on Monday, April 17th. Raymond James reissued a “strong-buy” rating and set a $630.00 price objective on shares of UnitedHealth Group in a research report on Friday, April 14th. Piper Sandler initiated coverage on UnitedHealth Group in a report on Thursday. They set an “overweight” rating for the company. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $592.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. Two equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $600.19.
UnitedHealth Group Stock Down 0.7 %
UnitedHealth Group (NYSE:UNH – Get Rating) last released its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating the consensus estimate of $6.24 by $0.02. The firm had revenue of $91.93 billion for the quarter, compared to analyst estimates of $89.77 billion. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The company’s quarterly revenue was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.49 earnings per share.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Chelsea Counsel Co. bought a new position in UnitedHealth Group during the fourth quarter worth about $27,000. 25 LLC bought a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $28,000. Cascade Investment Advisors Inc. bought a new position in UnitedHealth Group during the 1st quarter worth $28,000. Freedom Wealth Alliance LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $31,000. Finally, Kalos Management Inc. bought a new position in shares of UnitedHealth Group in the first quarter worth $34,000. 86.31% of the stock is owned by institutional investors and hedge funds.
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,684 shares of the company’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $488.46, for a total value of $822,566.64. Following the sale, the executive vice president now owns 8,675 shares in the company, valued at $4,237,390.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,684 shares of the firm’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $488.46, for a total transaction of $822,566.64. Following the completion of the sale, the executive vice president now owns 8,675 shares of the company’s stock, valued at approximately $4,237,390.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Andrew Witty sold 6,160 shares of the stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares in the company, valued at $42,199,084.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,852 shares of company stock valued at $4,313,962. 0.35% of the stock is owned by company insiders.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 21st. Stockholders of record on Monday, March 13th were given a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date was Friday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 30.18%.
About UnitedHealth Group
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.